A Valuation Reset, Not a Fundamentals Problem
After five consecutive weeks of selling pressure, markets have shown signs of stabilization, with major averages posting roughly 3% gains. But what does this environment really mean for investors? The current pullback is best understood not as a breakdown in fundamentals, but as a valuation reset. Earnings expectations have actually continued to move higher even as stock prices have retreated. The market is currently being driven by three forces: higher oil prices, rising interest rates, and geopolitical uncertainty — and for now, uncertainty is winning.
The key takeaway is that opportunity still exists for those who know where to look. The challenge is being disciplined and selective about where to allocate capital.
A Framework for Picking Stocks in Volatile Markets
In an environment where conflict is spiking oil prices, fueling inflation, and putting pressure on growth, the playbook shifts. Rather than chasing fast-growing momentum names, the emphasis should fall on quality and selectivity. Several principles stand out:
- Durable earnings over fast earnings. Consistency matters more than explosive growth when the macro backdrop is uncertain.
- Pricing power. Companies that can pass along rising costs without destroying demand are best positioned to weather inflationary pressure.
- Strong balance sheets. Financial health matters again after years of easy money. Companies with significant cash flow and low leverage have the flexibility to navigate turbulence.
- Valuation discipline. Paying a reasonable price for visible earnings is critical — avoid speculation and stick with names where fundamentals are already showing up in the numbers.
The strategic asset allocation framework stays intact, but the tactical emphasis tilts toward sectors with clear fundamentals and visible earnings trajectories. Two areas stand out: technology tied to AI monetization and healthcare driven by innovation.
Eli Lilly and the GLP-1 Revolution
Eli Lilly represents one of the clearest growth stories in the market today. The GLP-1 drug category — which began as a diabetes treatment and has expanded into weight loss — is generating sustained, strong demand and real earnings growth. With the recent development of oral GLP-1 formulations, the addressable market expands dramatically, bringing in the large population of patients who are needle-averse.
Lilly checks every box in the quality framework: durable earnings backed by genuine innovation, strong pricing power in a high-demand category, and a non-cyclical business model. Despite being down roughly 13% from its highs above $1,100, the long-term trajectory remains compelling. The GLP-1 trend is not going away, and Lilly is positioned to be a dominant player in what could be a transformative shift in healthcare.
Microsoft: AI Already Driving Real Revenue
Microsoft has had a rough stretch — down over 20% year to date, its worst first quarter in 17 years. But the investment case rests on substance, not hype. Unlike many AI-adjacent names where monetization remains theoretical, Microsoft is a platform where artificial intelligence is already embedded and driving real revenue.
The bull case centers on recurring revenue across cloud and enterprise, deep integration into customer workflows that creates significant switching costs, a strong balance sheet with substantial cash flow, and — crucially — the fact that AI monetization is already happening, not just promised. Microsoft is not a speculative AI bet. It is a quality company where the AI tailwind is showing up in actual financial results.
Broadcom: The Infrastructure Play on AI
Broadcom represents the infrastructure side of the AI buildout. While Microsoft captures the software and platform layer, Broadcom benefits from the hardware and networking demand that underpins the entire AI ecosystem. The company's investment appeal rests on long-term contracts, recurring demand, highly specialized products with limited substitution options, and strong cash flow that supports both growth and shareholder returns.
The earnings visibility at Broadcom supports its valuation multiple, making it a disciplined way to gain exposure to the AI infrastructure theme without paying speculative prices.
The Bottom Line
The current market environment rewards patience, selectivity, and a focus on quality. Historical precedent — including past military conflicts — suggests that markets tend to recover and move higher once uncertainty begins to clear. The key is not to panic during the drawdown, but to position portfolios in companies where the fundamentals are already visible in the numbers. Names like Eli Lilly, Microsoft, and Broadcom are not speculative bets on future possibilities. They are high-quality businesses with durable earnings, pricing power, and strong balance sheets — exactly what this market environment demands.